Q Biomed looks to dust off shelved cancer pain drug

Denis Corin has spent the last 13 years in the biopharmaceutical industry watching and learning from scientists and companies that fail. “I’ve seen so many promising and innovative young technologies really struggle along or die on the vine because they’re run by...

http://www.visionmonday.com/latest-news/article/q-biomed-inc-and-mannin-research-inc-sign-definitive-license-agreement-1/

Northwestern researchers’ glaucoma breakthrough prompts new treatment...

http://consumer.healthday.com/eye-care-information-13/eye-and-vision-problem-news-295/researchers-probe-molecular-cause-for-glaucoma-691598.html